ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Portland, OR

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma

Prostate Cancer trials near Portland, OR, USA:

Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)

The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...

Active, not recruiting
Prostate Cancer
Biological: placebo
Drug: valacyclovir

Phase 2

Candel Therapeutics

Portland, Oregon, United States and 22 other locations

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Portland, Oregon, United States and 34 other locations

The purpose of this study is to learn whether PYLARIFY PET imaging (study scan) can safely and accurately detect the presence or absence of prostate...

Active, not recruiting
Prostate Cancer
Drug: Piflufolastat F 18 Intravenous Solution [PYLARIFY]

Phase 4

Lantheus Medical Imaging
Lantheus Medical Imaging

Portland, Oregon, United States and 13 other locations

Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...

Enrolling
Prostate Adenocarcinoma
Prostate Cancer
Drug: Copper Cu 64 PSMA I&T

Phase 3

Curium

Portland, Oregon, United States and 42 other locations

The main purpose of the study is to assess the safety and tolerability of AZD2284, AZD2287, and AZD2275.

Enrolling
Metastatic Castration-Resistant Prostate Cancer
Drug: AZD2287
Drug: AZD2275

Phase 1

AstraZeneca
AstraZeneca

Portland, Oregon, United States and 14 other locations

This clinical trial investigates the change in prostate-specific membrane antigen (PSMA) expression in response to hormonal therapy in both, ...

Enrolling
Prostate Adenocarcinoma
Castration Sensitive Prostate Cancer
Other: Electronic Health Record Review
Drug: Piflufolastat

Phase 4

OHSU Knight Cancer Institute
OHSU Knight Cancer Institute

Portland, Oregon, United States

inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...

Active, not recruiting
Metastatic Castration Resistant Prostate Cancer
Drug: Pembrolizumab

Phase 2

VA Office of Research and Development
VA Office of Research and Development

Portland, Oregon, United States and 12 other locations

radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...

Active, not recruiting
Prostate Cancer
Biological: Placebo + valacyclovir
Biological: Aglatimagene besadenovec + valacyclovir

Phase 3

Candel Therapeutics

Portland, Oregon, United States and 72 other locations

with abiraterone acetate plus prednisone has on the patient and the prostate cancer. Abiraterone acetate plus prednisone are drugs ...

Active, not recruiting
Prostate Cancer
Drug: Ipilimumab

Phase 1, Phase 2

Memorial Sloan Kettering Cancer Center (MSK)
Memorial Sloan Kettering Cancer Center (MSK)

Portland, Oregon, United States and 2 other locations

the inheritance of prostate cancer. If a gene or genes that cause prostate cancer can be found, the diagnosis an ...

Active, not recruiting
Castration-Sensitive Prostate Carcinoma
Metastatic Prostate Carcinoma
Procedure: Computed Tomography
Drug: Abiraterone Acetate

Phase 2

OHSU Knight Cancer Institute
OHSU Knight Cancer Institute

Portland, Oregon, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems